---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-088494"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2026-03-03T23:59:59+00:00"
generated_at: "2026-05-15T22:17:42.568802+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Iterum Therapeutics requests Nasdaq hearing to appeal delisting; warns of possible wind-down

## Summary
- On March 3, 2026, Iterum requested a hearing before Nasdaq Hearings Panel to appeal delisting for failure to maintain $1.00 bid price.
- Hearing request automatically stays suspension scheduled for March 5, 2026, pending the hearing and any extension.
- Company also fails to meet $35M minimum market value of listed securities requirement; compliance deadline June 9, 2026.
- Evaluating strategic alternatives including possible wind-down, bankruptcy, licensing or sale of assets.
- Company states limited ability to raise capital; shareholders very unlikely to receive distribution in a wind-down.

## SEC filing metadata
- accession: 0001193125-26-088494
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2026-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000119312526088494/0001193125-26-088494-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000119312526088494/itrm-20260303.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-088494
- JSON: https://secwatch.observer/filing/0001193125-26-088494.json
- Plain text: https://secwatch.observer/filing/0001193125-26-088494.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.